CD4 and systemic lupus erythematosus: Upregulating miR-17-92 in mice facilitates the spontaneous activation and abnormal expansion of CD4+ T cells, and skews CD4+T cell differentiation toward Tfh cells, thus contributing to lymphoproliferative diseases and SLE-like symptoms (68, 124).